These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3329719)
1. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line. Colletta G; Cirafici AM; Consiglio E; Vecchio G Oncogene Res; 1987; 1(4):459-66. PubMed ID: 3329719 [TBL] [Abstract][Full Text] [Related]
2. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli. Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313 [TBL] [Abstract][Full Text] [Related]
3. TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line. Portella G; Vitagliano D; Li Z; Sferratore F; Santoro M; Vecchio G; Fusco A Oncol Res; 1998; 10(9):441-7. PubMed ID: 10223619 [TBL] [Abstract][Full Text] [Related]
4. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells. Baptist M; Dumont JE; Roger PP Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241 [TBL] [Abstract][Full Text] [Related]
5. Control of c-fos and c-myc proto-oncogene induction in rat thyroid cells in culture. Isozaki O; Kohn LD Mol Endocrinol; 1987 Nov; 1(11):839-48. PubMed ID: 2856403 [TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888 [TBL] [Abstract][Full Text] [Related]
7. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point. Gogusev J; Barbey S; Nezelof C Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523 [TBL] [Abstract][Full Text] [Related]
8. Human Harvey-ras is biochemically different from Kirsten- or N-ras. Carbone A; Gusella GL; Radzioch D; Varesio L Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005 [TBL] [Abstract][Full Text] [Related]
9. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells. Cao W; Li F; Steinberg RH; LaVail MM Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800 [TBL] [Abstract][Full Text] [Related]
11. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes. Kohl NE; Ruley HE Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582 [TBL] [Abstract][Full Text] [Related]
12. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes. Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335 [TBL] [Abstract][Full Text] [Related]
13. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum. Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742 [TBL] [Abstract][Full Text] [Related]
14. Differential induction of transcription of c-myc and c-fos proto-oncogenes by 12-O-tetradecanoylphorbol-13-acetate in mortal and immortal human urothelial cells. Skouv J; Christensen B; Autrup H J Cell Biochem; 1987 Jun; 34(2):71-9. PubMed ID: 3597558 [TBL] [Abstract][Full Text] [Related]
15. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype. Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341 [TBL] [Abstract][Full Text] [Related]
16. Ultraviolet light induces the expression of oncogenes in rat fibroblast and human keratinocyte cells. Ronai ZA; Okin E; Weinstein IB Oncogene; 1988 Feb; 2(2):201-4. PubMed ID: 3285298 [TBL] [Abstract][Full Text] [Related]
17. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation. Curran T; Bravo R; Müller R Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686 [TBL] [Abstract][Full Text] [Related]
18. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1. Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882 [TBL] [Abstract][Full Text] [Related]
19. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells. Portella G; Vitagliano D; Borselli C; Melillo RM; Salvatore D; Rothstein JL; Vecchio G; Fusco A; Santoro M Oncol Res; 1999; 11(9):421-7. PubMed ID: 10821536 [TBL] [Abstract][Full Text] [Related]
20. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo. Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]